fda compounding glp-1 warning letters october 2025 The has received hundreds of adverse event reports tied to compounded GLP-1s. PRI's brief warns that patients should know the risks before trusting knockoff versions. Read the brief: https://medecon.org/unauthorized-glp-1-knockoffs/ Trends In FDA FY 2025

These medications have increased in popularity over the past few years, and there is a lot of interest - especially in women who are wanting to lost weight postpartum

This case highlights the need for gradual insulin tapering and close monitoring while transitioning from insulin therapy to GIP/GLP-1 receptor agonists.

GLP-1 receptor agonists may be used in some ulcerative colitis patients, but require individualized assessment

Our randomized, placebo-controlled trial of tirzepatide (Zepbound) for #LongCovid has already enrolled >500 participants of 1000 planned in less than 2 weeks!

Freezer-safe Oven-safe to 450F Microwave-safe Dishwasher-safe 100% BPA-free Shop with Razab & 30% off meal prep containers.

No Friday shipments.